United Pharm (033270) — Long-term Investment Intensity
United Pharm (033270) has a Long-term Investment Intensity of 5.3% as of September 2015. Long-term investments of ₩11.90 Billion represent 5.3% of total assets of ₩223.90 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 033270 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
United Pharm Long-term Investment Intensity (2011–2014)
This chart shows how United Pharm's Long-term Investment Intensity has evolved across 4 annual periods from 2011 to 2014. As of September 2015, the intensity stands at 5.3%, reflecting long-term investments of ₩11.90 Billion against total assets of ₩223.90 Billion KRW. Explore United Pharm cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for United Pharm (2011–2014)
The table below presents the year-by-year Long-term Investment Intensity for United Pharm from 2011 to 2014, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see United Pharm market cap and net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2014 | 5.6% | ₩12.07 Billion | ₩217.10 Billion | ▲ +1.1 pp |
| 2013 | 4.5% | ₩8.71 Billion | ₩193.54 Billion | ▲ +0.0 pp |
| 2012 | 4.5% | ₩8.43 Billion | ₩187.58 Billion | ▼ -0.5 pp |
| 2011 | 5.0% | ₩8.49 Billion | ₩170.09 Billion | — |